|
1
|
Bjurholm A, Kreicbergs A, Brodin E and
Schultzberg M: Substance P- and CGRP-immunoreactive nerves in bone.
Peptides. 9:165–171. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Imai S and Matsusue Y: Neuronal regulation
of bone metabolism and anabolism: Calcitonin gene-related peptide-,
substance P- and tyrosine hydroxylase-containing nerves and the
bone. Microsc Res Tech. 58:61–69. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kawase T, Okuda K and Burns DM: Immature
human osteoblastic MG63 cells predominantly express a subtype
1-like CGRP receptor that inactivates extracellular signal response
kinase by a cAMP-dependent mechanism. Eur J Pharmacol. 470:125–137.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schinke T, Liese S, Priemel M, Haberland
M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel
RF, Emeson RB and Amling M: Decreased bone formation and osteopenia
in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner
Res. 19:2049–2056. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Togari A, Arai M, Mizutani S, Mizutani S,
Koshihara Y and Nagatsu T: Expression of mRNAs for neuropeptide
receptors and beta-adrenergic receptors in human osteoblasts and
human osteogenic sarcoma cells. Neurosci Lett. 233:125–128. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tuo Y, Guo X, Zhang X, Wang Z, Zhou J, Xia
L, Zhang Y, Wen J and Jin D: The biological effects and mechanisms
of calcitonin gene-related peptide on human endothelial cell. J
Recept Signal Transduct Res. 33:114–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Uzan B, de Vernejoul MC and Cressent M:
RAMPs and CRLR expressions in osteoblastic cells after
dexamethasone treatment. Biochem Biophys Res Commun. 321:802–808.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Villa I, Mrak E, Rubinacci A, Ravasi F and
Guidobono F: CGRP inhibits osteoprotegerin production in human
osteoblast-like cells via cAMP/PKA-dependent pathway. Am J Physiol
Cell Physiol. 291:C529–C537. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wimalawansa SJ: Calcitonin gene-related
peptide and its receptors: Molecular genetics, physiology,
pathophysiology and therapeutic potentials. Endocr Rev. 17:533–585.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wimalawansa SJ: Amylin, calcitonin
gene-related peptide, calcitonin and adrenomedullin: A peptide
superfamily. Crit Rev Neurobiol. 11:167–239. 1997. View Article : Google Scholar
|
|
11
|
Fang Z, Yang Q, Xiong W, Li GH, Liao H,
Xiao J and Li F: Effect of CGRP-adenoviral vector transduction on
the osteoblastic differentiation of rat adipose-derived stem cells.
PLoS One. 8:e727382013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YS, Wang YH, Zhao GQ and Li YB:
Osteogenic potential of human calcitonin gene-related peptide alpha
gene-modified bone marrow mesenchymal stem cells. Chin Med J
(Engl). 124:3976–3981. 2011.
|
|
13
|
Xu J, Kauther MD, Hartl J and Wedemeyer C;
Study was performed at the University of Duisburg-Essen, Germany:
Effects of alpha-calcitonin gene-related peptide on osteoprotegerin
and receptor activator of nuclear factor-κB ligand expression in
MG-63 osteoblast-like cells exposed to polyethylene particles. J
Orthop Surg Res. 5:832010. View Article : Google Scholar
|
|
14
|
Yoo YM, Kwag JH, Kim KH and Kim CH:
Effects of neuropeptides and mechanical loading on bone cell
resorption in vitro. Int J Mol Sci. 15:5874–5883. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ballica R, Valentijn K, Khachatryan A,
Guerder S, Kapadia S, Gundberg C, Gilligan J, Flavell RA and
Vignery A: Targeted expression of calcitonin gene-related peptide
to osteoblasts increases bone density in mice. J Bone Miner Res.
14:1067–1074. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huebner AK, Schinke T, Priemel M,
Schilling S, Schilling AF, Emeson RB, Rueger JM and Amling M:
Calcitonin deficiency in mice progressively results in high bone
turnover. J Bone Miner Res. 21:1924–1934. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim SY, Kim S, Yun-Choi HS and Jho EH:
Wnt5a potentiates U46619-induced platelet aggregation via the
PI3K/Akt pathway. Mol Cells. 32:333–336. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng Q, Chen P, Xu Z, Li F and Yi XP:
Expression and redistribution of β-catenin in the cardiac myocytes
of left ventricle of spontaneously hypertensive rat. J Mol Histol.
44:565–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JH, Kim BG, Ahn JM, Park HJ, Park SK,
Yoo JS, Yates JR III and Cho JY: Role of PI3K on the regulation of
BMP2-induced beta-Catenin activation in human bone marrow stem
cells. Bone. 46:1522–1532. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Li J and Chen B: Oct4 was a novel
target of Wnt signaling pathway. Mol Cell Biochem. 362:233–240.
2012. View Article : Google Scholar
|
|
21
|
Liu Y, Liu Y, Zhang R, Wang X, Huang F,
Yan Z, Nie M, Huang J, Wang Y, Wang Y, et al: All-trans retinoic
acid modulates bone morphogenic protein 9-induced osteogenesis and
adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin
signaling pathways. Int J Biochem Cell Biol. 47:47–56. 2014.
View Article : Google Scholar
|
|
22
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peterson-Nedry W, Erdeniz N, Kremer S, Yu
J, Baig-Lewis S and Wehrli M: Unexpectedly robust assembly of the
Axin destruction complex regulates Wnt/Wg signaling in Drosophila
as revealed by analysis in vivo. Dev Biol. 320:226–241. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salins P, Shawesh S, He Y, Dibrov A,
Kashour T, Arthur G and Amara F: Lovastatin protects human neurons
against Abeta-induced toxicity and causes activation of
beta-catenin-TCF/LEF signaling. Neurosci Lett. 412:211–216. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun YC: Examination of effects of GSK3beta
phosphorylation, beta-catenin phosphorylation and beta-catenin
degradation on kinetics of Wnt signaling pathway using
computational method. Theor Biol Med Model. 6:132009. View Article : Google Scholar
|
|
26
|
Weng X, Lin P, Liu F, Chen J, Li H, Huang
L, Zhen C, Xu H, Liu X, Ye H and Li X: Achyranthes bidentata
polysaccharides activate the Wnt/β-catenin signaling pathway to
promote chondrocyte proliferation. Int J Mol Med. 34:1045–1050.
2014.PubMed/NCBI
|
|
27
|
Wen X, Cawthorn WP, MacDougald OA, Stupp
SI, Snead ML and Zhou Y: The influence of Leucine-rich amelogenin
peptide on MSC fate by inducing Wnt10b expression. Biomaterials.
32:6478–6486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Georgiou KR, King TJ, Scherer MA, Zhou H,
Foster BK and Xian CJ: Attenuated Wnt/β-catenin signalling mediates
methotrexate chemotherapy-induced bone loss and marrow adiposity in
rats. Bone. 50:1223–1233. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo J, Liu M, Yang D, Bouxsein ML, Saito
H, Galvin RJ, Kuhstoss SA, Thomas CC, Schipani E, Baron R, et al:
Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated
stromal cell response and new bone formation. Cell Metab.
11:161–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tamura M, Sato MM and Nashimoto M:
Regulation of CXCL12 expression by canonical Wnt signaling in bone
marrow stromal cells. Int J Biochem Cell Biol. 43:760–767. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu HM, Yang L, Wang Z, Liu YW, Fan JZ, Fan
J, Liu J and Luo ZJ: Overexpression of integrin a2 promotes
osteogenic differentiation of hBMSCs from senile osteoporosis
through the ERK pathway. Int J Clin Exp Pathol. 6:841–852.
2013.PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Sharma AR, Choi BS, Park JM, Lee DH, Lee
JE, Kim HS, Yoon JK, Song DK, Nam JS and Lee SS: Rspo 1 promotes
osteoblast differentiation via Wnt signaling pathway. Indian J
Biochem Biophys. 50:19–25. 2013.PubMed/NCBI
|
|
34
|
Bloom AP, Jimenez-Andrade JM, Taylor RN,
Castañeda-Corral G, Kaczmarska MJ, Freeman KT, Coughlin KA,
Ghilardi JR, Kuskowski MA and Mantyh PW: Breast cancer-induced bone
remodeling, skeletal pain and sprouting of sensory nerve fibers. J
Pain. 12:698–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eberhardt M, Dux M, Namer B, Miljkovic J,
Cordasic N, Will C, Kichko TI, de la Roche J, Fischer M, Suárez SA,
et al: H2S and NO cooperatively regulate vascular tone by
activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. Nat
Commun. 5:43812014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sample SJ, Hao Z, Wilson AP and Muir P:
Role of calcitonin gene-related peptide in bone repair after cyclic
fatigue loading. PLoS One. 6:e203862011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shui C, Spelsberg TC, Riggs BL and Khosla
S: Changes in Runx2/Cbfa1 expression and activity during
osteoblastic differentiation of human bone marrow stromal cells. J
Bone Miner Res. 18:213–221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hoppler S and Kavanagh CL: Wnt signalling:
Variety at the core. J Cell Sci. 120:385–393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee JE, Wu SF, Goering LM and Dorsky RI:
Canonical Wnt signaling through Lef1 is required for hypothalamic
neurogenesis. Development. 133:4451–4461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimizu N, Kawakami K and Ishitani T:
Visualization and exploration of Tcf/Lef function using a highly
responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
Dev Biol. 370:71–85. 2012. View Article : Google Scholar : PubMed/NCBI
|
